The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 31.04%. However, over
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lineage Cell Therapeutics Inc’s current trading price is -58.07% away from its 52-week high, while its distance from the 52-week low is
Lineage Cell Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $1.61 on 03/28/24 and a low of $0.48 for the same time frame on 12/30/24. 52-week price history of LCTX Stock A stock’s 52-week high
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 15.94%.However, over the last six months, we can see a
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Lineage Cell Therapeutics Inc’s current trading price is -68.01% away from its 52-week high, while its distance from the 52-week
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Lineage Cell Therapeutics Inc’s current trading price is -68.68% away from its 52-week high, while its distance from the 52-week low is 4.84%. The
The market performance of Lineage Cell Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.61 on 03/28/24, while the lowest value for the same duration was $0.48 on 12/17/24. 52-week price history
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -46.78%.However, over the last six months, we can see a stronger performance of -37.56%. Over
All rights reserved © 2024, Powered By Smart TechOne
